Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatry Advisor
Recent findings indicate a significant association between SSRI use in children and delayed puberty, with an odds ratio of 1.44. This underscores the importance of considering potential developmental impacts when prescribing these medications.
Child & Adolescent Psychiatry November 7th 2023
Psychiatrist.com
This case underscores the importance of understanding PANDAS and its management. Despite multiple rounds of treatment including antibiotics, intravenous immunoglobulin treatment (IVIG), plasmapheresis, antipsychotics, mood stabilizers, antidepressants/anxiolytics, adenotonsillectomy, individual psychotherapy, and partial hospitalization programs, the patient’s condition remained resistant.
Child & Adolescent Psychiatry October 24th 2023
MDLinx
The recent surge in ADHD medication-related errors is a pressing concern that demands immediate attention from healthcare providers. Learn how you can minimize risks and improve patient safety.
Child & Adolescent Psychiatry September 27th 2023
Psych Congress Network
Discover how viloxazine ER could offer a new avenue for enhancing ADHD treatment efficacy in pediatric patients with inadequate response to stimulants.
Gain insights into the complexities of diagnosing ADHD, especially in transitional life periods, and learn why a nuanced approach is essential for effective treatment.
Child & Adolescent Psychiatry September 12th 2023
Discover the latest advancements in ADHD therapies that promise greater efficacy and fewer side effects—options that can revolutionize personalized treatment plans.
Child & Adolescent Psychiatry September 6th 2023